Prontogest Solution for IM Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Prontogest Solution for IM Injection, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection [Phase 1]